Back to all studies
Enrolling By InvitationNCT07670702

Long-term Safety and Efficacy of TSND-201 for PTSD

This study is enrolling by invitation in the United States. It is testing Long-term Safety and Efficacy of TSND-201 for PTSD.

PTSDDrug

The public registry lists enrollment by invitation. This is not open recruitment; contact the research team to understand who may be invited.

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether the Long-Term Safety and Efficacy of TSND-201 may be useful for people experiencing ptsd.

What would participation involve?

Participants may receive the Long-Term Safety and Efficacy of TSND-201, attend study visits with the research team. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for people with ptsd.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: June 22, 2026
Recruitment status
Enrolling By Invitation
Enrollment listed in the registry
300
Sponsor
Transcend Therapeutics
Sponsor type
Biotech company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
Not clearly listed
Official registry ID
NCT07670702
Official title
A Phase 3 Open-Label Extension Study to Assess the Long-term Safety and Efficacy of TSND-201 for the Treatment of PTSD

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT07670702. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 17 sites
  • Preferred Research Partners
    Little Rock, Arkansas
    Site status: Not listed — confirm with the team
  • CalNeuro Research Group
    Los Angeles, California
    Site status: Not listed — confirm with the team
  • Catalina Research Institute
    Montclair, California
    Site status: Not listed — confirm with the team
  • Starlight Clinical Research
    Evergreen, Colorado
    Site status: Not listed — confirm with the team
  • Clinical Neuroscience Solutions - Jacksonville
    Jacksonville, Florida
    Site status: Not listed — confirm with the team
  • Segal Trials
    Lauderhill, Florida
    Site status: Not listed — confirm with the team
  • Accel Clinical Research
    Maitland, Florida
    Site status: Not listed — confirm with the team
  • CNS Healthcare
    Orlando, Florida
    Site status: Not listed — confirm with the team
  • Vitalix Clinical
    Worcester, Massachusetts
    Site status: Not listed — confirm with the team
  • Arch Clinical Trials
    Creve Coeur, Missouri
    Site status: Not listed — confirm with the team
  • Bio Behavioral Health
    Toms River, New Jersey
    Site status: Not listed — confirm with the team
  • Insight Clinical Trials
    Independence, Ohio
    Site status: Not listed — confirm with the team
  • Flourish Research
    Plymouth Meeting, Pennsylvania
    Site status: Not listed — confirm with the team
  • Austin Clinical Trial Partners
    Austin, Texas
    Site status: Not listed — confirm with the team
  • Haracec Clinical Research
    El Paso, Texas
    Site status: Not listed — confirm with the team
  • Cedar Clinical Research
    Draper, Utah
    Site status: Not listed — confirm with the team
  • Inner Space Research
    Orem, Utah
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with ptsd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving TSND-201. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with ptsd. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Transcend Therapeutics, which appears to be a biotech company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists enrollment by invitation. This is not open recruitment; contact the research team to understand who may be invited.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me